Stephens Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1M Buy
150,409
+2,721
+2% +$201K 0.15% 147
2025
Q1
$10.3M Buy
147,688
+44,270
+43% +$3.07M 0.15% 150
2024
Q4
$8.9M Sell
103,418
-55,463
-35% -$4.77M 0.12% 171
2024
Q3
$18.9M Buy
158,881
+37,585
+31% +$4.48M 0.27% 90
2024
Q2
$17.3M Buy
121,296
+23,934
+25% +$3.42M 0.26% 90
2024
Q1
$12.5M Buy
97,362
+28,116
+41% +$3.61M 0.19% 132
2023
Q4
$7.16M Buy
69,246
+4,245
+7% +$439K 0.12% 188
2023
Q3
$5.91M Sell
65,001
-3,437
-5% -$313K 0.11% 203
2023
Q2
$5.54M Sell
68,438
-9,066
-12% -$734K 0.1% 217
2023
Q1
$6.17M Buy
77,504
+12,628
+19% +$1M 0.12% 192
2022
Q4
$4.39M Sell
64,876
-1,276
-2% -$86.3K 0.09% 228
2022
Q3
$3.3M Buy
66,152
+2,884
+5% +$144K 0.07% 276
2022
Q2
$3.53M Sell
63,268
-286
-0.5% -$15.9K 0.07% 276
2022
Q1
$3.53M Sell
63,554
-2,680
-4% -$149K 0.06% 322
2021
Q4
$3.71M Sell
66,234
-2,372
-3% -$133K 0.06% 332
2021
Q3
$3.29M Sell
68,606
-64,084
-48% -$3.08M 0.05% 357
2021
Q2
$5.56M Buy
132,690
+46,750
+54% +$1.96M 0.08% 247
2021
Q1
$2.9M Buy
85,940
+18,196
+27% +$613K 0.05% 370
2020
Q4
$2.37M Buy
67,744
+2,158
+3% +$75.4K 0.04% 385
2020
Q3
$2.28M Buy
65,586
+502
+0.8% +$17.4K 0.04% 366
2020
Q2
$2.13M Sell
65,084
-32,292
-33% -$1.06M 0.05% 364
2020
Q1
$2.93M Buy
97,376
+2,206
+2% +$66.4K 0.08% 266
2019
Q4
$2.75M Buy
95,170
+4,796
+5% +$139K 0.06% 330
2019
Q3
$2.34M Buy
90,374
+2,720
+3% +$70.3K 0.05% 353
2019
Q2
$2.24M Buy
87,654
+7,262
+9% +$185K 0.05% 385
2019
Q1
$2.1M Buy
80,392
+7,514
+10% +$197K 0.05% 387
2018
Q4
$1.68M Buy
72,878
+5,114
+8% +$118K 0.05% 402
2018
Q3
$1.6M Buy
+67,764
New +$1.6M 0.04% 452
2017
Q3
Sell
-89,286
Closed -$1.92M 820
2017
Q2
$1.92M Buy
89,286
+19,456
+28% +$417K 0.07% 297
2017
Q1
$1.2M Buy
69,830
+42,306
+154% +$725K 0.04% 378
2016
Q4
$494K Buy
+27,524
New +$494K 0.02% 493